Victory Capital Management Inc Oric Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

$95.8 Billion
Q2 2024

A detailed history of Victory Capital Management Inc transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 95,850 shares of ORIC stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

95,850

Previous 88,540 8.26%

Holding current value

$1.02 Million

Previous $1.22 Million 44.37%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$6.63 - $12.93 $48,465 - $94,518	7,310 Added 8.26%	95,850 $677,000
Q1 2024 May 03, 2024	SELL	$8.04 - $16.03 $301,419 - $600,964	-37,490 Reduced 29.75%	88,540 $1.22 Million
Q4 2023 Feb 05, 2024	BUY	$5.41 - $9.43 $6,383 - $11,127	1,180 Added 0.95%	126,030 $1.16 Million
Q3 2023 Nov 06, 2023	SELL	$6.05 - $9.28 $73,689 - $113,030	-12,180 Reduced 8.89%	124,850 $755,000
Q2 2023 Jul 27, 2023	SELL	$4.95 - $8.4 $105,930 - $179,760	-21,400 Reduced 13.51%	137,030 $1.06 Million
Q1 2023 May 02, 2023	BUY	$4.26 - $6.75 $674,911 - $1.07 Million	158,430 New	158,430 $903,000
Q3 2022 Nov 02, 2022	SELL	$3.15 - $5.24 $1,508 - $2,509	-479 Reduced 1.0%	47,479 $152,000
Q2 2022 Aug 01, 2022	BUY	$2.7 - $7.07 $105 - $275	39 Added 0.08%	47,958 $215,000
Q1 2022 May 04, 2022	SELL	$4.54 - $16.1 $7.98 Million - $28.3 Million	-1,757,798 Reduced 97.35%	47,919 $159,000
Q4 2021 Feb 07, 2022	BUY	$12.01 - $20.3 $3.12 Million - $5.27 Million	259,394 Added 16.77%	1,805,717 $26.5 Million
Q3 2021 Nov 02, 2021	BUY	$15.9 - $25.22 $3.85 Million - $6.1 Million	241,963 Added 18.55%	1,546,323 $32.3 Million
Q2 2021 Aug 03, 2021	BUY	$17.37 - $25.34 $3.46 Million - $5.04 Million	198,986 Added 18.0%	1,304,360 $23.1 Million
Q1 2021 May 04, 2021	BUY	$23.67 - $36.85 $120,267 - $187,234	5,081 Added 0.46%	1,105,374 $27.1 Million
Q4 2020 Feb 01, 2021	BUY	$20.32 - $39.8 $4.13 Million - $8.09 Million	203,159 Added 22.65%	1,100,293 $37.2 Million
Q3 2020 Nov 09, 2020	BUY	$19.5 - $31.26 $6.42 Million - $10.3 Million	329,014 Added 57.91%	897,134 $22.4 Million
Q2 2020 Aug 07, 2020	BUY	$25.68 - $38.12 $14.6 Million - $21.7 Million	568,120 New	568,120 $19.2 Million

Others Institutions Holding ORIC

# of Institutions

112

Shares Held

63.1M

Call Options Held

Put Options Held

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $421M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Oric Pharmaceuticals, Inc. Transaction History